Filters: keyword is Behavior [Clear All Filters]
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30. DOI
- 2007
Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior,
Eur J Pharm Sci, vol. 32, no. 3, pp. 200-8. DOI
Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies,
Eur J Pharm Sci, vol. 30, no. 1, pp. 45-55. DOI
- 2005
Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain,
Eur J Pharmacol, vol. 514, no. 2-3, pp. 131-40. DOI
- 2004
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat,
Epilepsia, vol. 45, no. 5, pp. 424-35. DOI
- 2003
Characterization of the pharmacokinetics, brain distribution, and therapeutic efficacy of the adenosine A1 receptor partial agonist 2'-deoxy-N6-cyclopentyladenosine in sarin-poisoned rats,
Toxicol Appl Pharmacol, vol. 192, no. 1, pp. 86-94. DOI
- 1998
Phamacokinetic-pharmacodynamic modelling of behavioural responses,
Neurosci Biobehav Rev, vol. 23, no. 2, pp. 229-36. DOI
- 1997
Seizure patterns in kindling and cortical stimulation models of experimental epilepsy,
Brain Res, vol. 770, no. 1-2, pp. 221-7. DOI
- 1992
Properties of the convulsive threshold determined by direct cortical stimulation in rats,
Epilepsy Res, vol. 12, no. 2, pp. 111-20.


